Tap, Pay, Spend: A Study on UPI Usage and Consumer Spending Behavior in India
International Journal of Advanced Research in Science Communication and Technology · 29.04.2026 · 444
DOI: 10.48175/ijarsct-34362 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Research in Science Communication and Technology, online erschienen am 29.04.2026. Verfasst von Harsh R. Sureka. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
This research examines the impact of Unified Payments Interface (UPI) usage on consumer spending patterns in India as part of the "Tap, Pay, Spend" phenomenon. As digital payment platforms are increasingly being used, UPI is increasingly popular because it is fast, easy to use and accessible. This study seeks to determine whether there is a significant impact on consumer spending behavior from the growth in UPI usage. The study used a survey questionnaire to gather primary data, and statistical methods like correlation and regression analysis to test the hypothesis. Results show that UPI usage has a substantial effect on consumers' spending patterns, especially in terms of frequency of transactions and impulsive buying. This research underscores the psychological effects of digital payments and the need for financial literacy.
Zitieren
APA
Sureka, H. R. (2026). Tap, Pay, Spend: A Study on UPI Usage and Consumer Spending Behavior in India. International Journal of Advanced Research in Science Communication and Technology, 444. https://doi.org/10.48175/ijarsct-34362
Vancouver
Sureka HR. Tap, Pay, Spend: A Study on UPI Usage and Consumer Spending Behavior in India. International Journal of Advanced Research in Science Communication and Technology. 2026:444. doi:10.48175/ijarsct-34362
BibTeX
@article{Sureka2026,
author = {Sureka, Harsh R.},
title = {Tap, Pay, Spend: A Study on UPI Usage and Consumer Spending Behavior in India},
journal = {International Journal of Advanced Research in Science Communication and Technology},
year = {2026},
pages = {444},
doi = {10.48175/ijarsct-34362}
}
EUVIMED